but the vast majority of people at risk of low blood glucose don’t carry an emergency kit. Supported by Xeris, the ADA wants to rectify low rates of glucagon prescriptions. The multi-year pact ...
The US regulator has approved the first non-injectable emergency medicine for diabetics who suffer potentially fatal low blood sugar levels. Eli Lilly’s intranasal formulation of glucagon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback